Mymetics Corporation

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mymetics Corporation.The latest application filed is for "oral dispersible vaccine comprising virosomes".

Company Profile

1.7.9

Mymetics Corporation - Epalinges CH
MYMETICS CORPORATION - New York NY
MYMETICS CORPORATION - Pittsburg PA
Mymetics Corp. - Annapolis MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Oral dispersible vaccine comprising virosomes Grant 11,224,571 - Wong , et al. January 18, 2	2022-01-18
Oral Dispersible Vaccine Comprising Virosomes App 20210386660 - WONG; Yik Teng ; et al.	2021-12-16
Oral Dispersible Vaccine Comprising Virosomes App 20200170933A1 -	2020-06-04
Virosome-like vesicles comprising gp41-derived antigens Grant 9,216,156 - Fleury , et al. December 22, 2	2015-12-22
Gp41 antigens Grant 8,765,137 - Fleury , et al. July 1, 2	2014-07-01
Splitting GP41 Grant 8,652,459 - Fleury , et al. February 18, 2	2014-02-18
Novel Gp41 Antigens App 20110311615 - Fleury; Sylvain ; et al.	2011-12-22
Splitting Gp41 App 20110311614 - Fleury; Sylvain ; et al.	2011-12-22
Soluble and stabilized trimeric form of gp41 polypeptides Grant 7,919,100 - Fleury , et al. April 5, 2	2011-04-05
Method For Synthesizing Conformationally Constrained Peptides, Peptidomimetics And The Use Thereof As Synthetic Vaccines App 20110008414 - Pluschke; Gerd ; et al.	2011-01-13
Method For Synthesizing Conformationally Constrained Peptides, Peptidomimetics And The Use Thereof As Synthetic Vaccines App 20090324707 - Pluschke; Gerd ; et al.	2009-12-31
Antibody or a fragment thereof, having neutralizing activity against hiv but not against il2 App 20090232826 - Bomsel; Morgane ; et al.	2009-09-17
Virosome-like Vesicles Comprising Gp41-derived Antigens App 20090202622 - Fleury; Sylvain ; et al.	2009-08-13
Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines Grant 7,569,541 - Pluschke , et al. August 4, 2	2009-08-04
Soluble And Stabilized Trimeric Form Of Gp41 Polypeptides App 20080213292 - Fleury; Sylvain ; et al.	2008-09-04
Peptides and use thereof in therapeutic agents against HIV infection App 20040002581 - Serres, Pierre F.	2004-01-01

Company Registrations

NCAGE Code	80W01	MYMETICS CORPORATION
CAGE Code	80W01	MYMETICS CORPORATION
S.A.M. Registration	80W01 [80960034]	MYMETICS CORPORATION
SEC	0000927761	MYMETICS CORP of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.